Clinical Trial Update: A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ONO-4578 in combination with Nivolumab and chemotherapy in chemotherapy-naïve patients with HER2-negative unresectable advan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Cancer
• Gastric Cancer

Drugs mentioned

• Chemotherapy (regimen not specified)
• ONO-4578
• nivolumab (nivolumab)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Gastric Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING